-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster III

Symposia: Acute Myeloid Leukemias: Commercially Available Therapies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Jason S. Gilbert1*, Megan Connor, MD1*, Grace Bosma, MS2*, Christine M. McMahon, MD3, Maria L Amaya, MD, PhD4, Jonathan Gutman, MD3, Marc Schwartz, MD5, Andrew Kent, MD, PhD3, Diana Abbott, PhD2 and Daniel A Pollyea, MD5

1Department of Medicine, University of Colorado School of Medicine, Aurora, CO
2Center for Innovative Design and Analysis (CIDA), Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado, Anschutz Medical Campus, Aurora, CO
3Division of Hematology, University of Colorado, Aurora, CO
4University of Colorado, Aurora, CO
5Division of Hematology, University of Colorado, Denver, CO

Luis E. Aguirre, MD1, Jan Philipp Bewersdorf, MD2, Yiwen Liu3*, Rory M. Shallis, MD4, Leora Boussi, MD5, Andrius Zucenka, MD6, Sylvain Garciaz, MD7*, Rebecca P. Bystrom, MD1, Daniel J. DeAngelo, MD, PhD1, Richard M. Stone, MD1, Marlise R. Luskin, MD1, Jacqueline S. Garcia, MD1, Eric S. Winer, MD1, Kelly Ling, PA-C1*, Evan C. Chen, MD1, Martha Wadleigh, MD1, Eytan M. Stein, MD5, Aaron D. Goldberg5, Amer M. Zeidan, MBBS, MHS8, Shai Shimony, MD1 and Maximilian Stahl, MD9

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, New Haven, CT
3Dana-Farber Cancer Institute, Boston, MA
4Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, Killingworth, CT
5Memorial Sloan Kettering Cancer Center, New York, NY
6Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
7Institut Paoli-Calmettes, MARSEILLE, France
8Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
9Dana Farber Cancer Institute, Boston, MA

Agnieszka Pluta1,2*, Olga Racinska1*, Magdalena Dutka3*, Karolina Beldzinska-Gondek3*, Jan Maciej Zaucha3*, Natalia Bujko-Wasiak4,5*, Katarzyna Brzezniakiewicz-Janus4,5*, Andrzej Szczepaniak, MD6*, Zuzanna Rzetelska6*, Lidia Gil, MD, PhD6, Ryszard Swoboda7*, Sebastian Giebel, MD, PhD7*, Marta Sobas, MD8*, Krzysztof Madry9*, Michal Górka9*, Grzegorz Basak9*, Anna Labedz10*, Malgorzata Razny10*, Agnieszka Kopacz11*, Kamila Kruczkowska-Tarantowicz12*, Piotr Rzepecki12*, Magdalena Czemerska1,2*, Piotr Strzalka1,2*, Kinga Krawiec1,2*, Jerzy Holowiecki7* and Agnieszka Wierzbowska1,2

1Department of Hematology, Medical University of Lodz, Lodz, Poland
2Department of Hematology and Transplantology, Multidisciplinary Provincial Centre of Traumatology and Oncology Nicolas Copernicus in Lodz, Lodz, Poland
3Department of Hematology and Transplantology, Medical University of Gdansk and University Clinical Center in Gdansk, Gdansk, Poland
4Department of Hematology, Multidisciplinary Provincial Hospital, Gorzów Wielkopolski, Poland
5Collegium Medicum, University of Zielona Góra, Gorzów Wielkopolski, Poland
6Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland
7Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
8Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University of Wroclaw, Wroclaw, Poland
9Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
10Hematology Department, Rydygier Memorial Hospital, Krakow, Poland
11Department of Hematology, Medical University of Rzeszow, Rzeszow, Poland
12Department of Clinical Hematology, Military Medical Academy, Warsaw, Poland

Baher Krayem, MD1*, Avraham Frisch, MD1*, Tsila Zuckerman, MD2, Israel Henig, MD1*, Dana Yehudai-Ofir, MD1*, Boaz Nachmias, MD, PhD3*, Hazim Khatib, MD1*, Arnon Haran3* and Shlomzion Aumann3*

1Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
2Department of Hematology and BMT, Rambam Health Care Campus, Haifa, Israel
3Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel

Onyee Chan, MD1, Kendra L. Sweet, MD1, Chetasi Talati, MD2, Fatima Tuz Zahra, MBBS3, Lisa Ann Nardelli, BS4*, Jatinder K. Lamba, PhD5, Jongphil Kim, PhD6*, Jinming Song, MD, PhD7*, Zhuoer Xie, MD, MS1, Seongseok Yun, MD, PhD1, Andrew T. Kuykendall, MD1, Eric Padron, MD1, Alison R. Walker, MD, MBA, MPH1, Rami S. Komrokji, MD1, Jeffrey E Lancet, MD1 and David Sallman, MD8

1Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
2AbbVie, Inc., Collierville, TN
3Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, ALBANY, NY
4Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL
5Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, FL
6Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
7Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Jennifer Croden, MD1, Danielle Hammond, MD1, Kelly S. Chien, MD2, Abhishek Maiti, MBBS3, George Donovan Tippett, BS, BSN, RN1*, Guillermo Montalban-Bravo, MD1, Michael Morales, BSN, RN4*, Nicholas J. Short, MD1, Hussein A. Abbas, MD, PhD1, Ghayas C. Issa, MD1, Tapan M. Kadia, MD1, Gautam Borthakur, MD5, Farhad Ravandi, MBBS6 and Courtney D. DiNardo, MD, MSc7

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, MD Anderson, Houston, TX
3Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX
4Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
5Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX

Vanthana Bharathi, MD1*, Alex Bataller, MD, PhD2*, Alexandre Bazinet, MD1*, Gautam Borthakur, MD3, Elias Jabbour, MD4, Naval Daver, MD5, Nicholas J. Short, MD1, Koichi Takahashi, MD, PhD1, Ghayas C. Issa, MD1, Courtney D. DiNardo, MD, MSc6, Naveen Pemmaraju, MD7, Nitin Jain, MD1, Guillermo Montalban-Bravo, MD1, William G. Wierda2, Farhad Ravandi, MBBS8, Hagop M. Kantarjian, MD1 and Tapan M. Kadia, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
5MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
8Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

Eshrak Al-Shaibani1*, Marta Beata Davidson, MD, PhD1, Aniket Bankar, MD, MBBS, MSc, DM1, Steven M. Chan, MD, PhD1, Hassan Sibai, MD1, Dawn C. Maze, MD, FRCPC, MSc1, Aaron D Schimmer, MD2, Mark D. Minden, MD, PhD1*, Karen Yee, MD, FRCPC1*, Vikas Gupta, MD, FRCP, FRCPath1, Andre C. Schuh, MD, FRCPC1 and Guillaume Richard-Carpentier, MD, FRCPC1

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

Jiajia Pan1,2,3,4*, Nianci Chen1,2,3,4*, Liping Mao, M.D.1,2,3,4*, Yinjun Lou, MD, PhD1,2,3,4*, Yi Zhang1,2,3,4*, Shanshan Suo, MD1,2,3,4*, Yile Zhou, MD1,2,3,4*, Chenying Li, PhD1,2,3,4*, Xia Li1,2,3,4*, Xueying Yang, M.D.1,2,3,4*, Qing Ling1,2,3,4*, Wenle Ye1,2,3,4*, Xiangjie Lin1,2,3,4*, Huafeng Wang1,2,3,4* and Jie Jin1,2,3,4

1Zhejiang Provincial Clinical Research Center for Hematological disorders, Hangzhou, China
2Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China
3Zhejiang University Cancer Center, Hangzhou, China
4Department of Hematology,the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Pierre-Yves Dumas, MD, PhD1*, Sarah Bertoli, MD2*, Clémence Santana3*, Mael Heiblig4*, Thibaut Leguay, MD5*, Suzanne Tavitian, MD6*, Eric Delabesse, MD, PhD7*, Émilie Klein, MD8*, Emmanuelle Tavernier, MD9*, Martin Carre, MD10*, Gaspar Aspas Requena11*, Anne Banos, MD12*, Norbert Vey, MD13, Arnaud Pigneux, MD, PhD14*, Christian Récher, MD, PhD15 and Sylvain Garciaz, MD16*

1CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, F-33000 Bordeaux, France;BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, Univ. Bordeaux, F-33000 Bordeaux, France, Bordeaux, France
2Service d'Hématologie, Centre Hospitalo-universitaire de Toulouse, Centre de Recherches en Cancérologie de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Université de Toulouse, UPS, INSERM, CNRS, Toulouse, France, Toulouse, France
3Département d'Hématologie, CH de Valence, Valence, France
4Hematology Department, Hospices Civils de Lyon, Pierre Bénite, Lyon, France, LYON, FRA
5Hematology, CHU Bordeaux, Hôpital du Haut-Lévêque, Pessac, France
6Department of Hematology, Toulouse University Cancer Institute Oncopole, Toulouse University Hospital, Toulouse, France
7University Hospital of Toulouse, University of Toulouse 3, Center of Research On, Toulouse, NA, FRA
8Service Hématologie Biologique, CHU Bordeaux, Bordeaux, France
9Département d'hématologie Clinique et de Thérapie Cellulaire, CHU Saint-Etienne, Saint-Etienne, France
10Clinical Hematology Department, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
11CHU Clermont-Ferrand, Clermont-Ferrand, France
12Centre Hospitalier De Bayonne, Bayonne, FRA
13Department of Hematology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM, Marseille, France
14Department of Clinical Hematology, Haut-Lévèque Hospital, CHU Bordeaux, Pessac, France
15Hematology Department, CHU deToulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
16Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France; Centre National de la Recherche Scientifique, UMR7258, Marseille, France; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille, France, Marseille, France

Xiwen Tong1*, Bin Xu1*, Shiyuan Zhang1*, Xiaojian Zhu1*, Mengyuan Li2*, Su Shuai1*, Yi Zhu1*, Zhenqian Huang3*, Yaya Wang3*, Yi Xiao1*, Liang Huang4, Dengju Li1*, Wei Huang1*, Jia Wei1, Mei Huang1*, Zhiping Huang5*, Yuanyan Tang5*, Hongbo Ren6* and Donghua Zhang1*

1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Department of hematology, Taihe Hospital, Hubei University of Medicine, Shiyan, China
3The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
4Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
5Jingzhou Central Hospital, Jingzhou, China
6Jingzhou First People’s Hospital, Jingzhou, China

Alexandre Bazinet, MD1*, Naval Daver, MD2, Farhad Ravandi, MBBS3, Nicholas J. Short, MD1, Musa Yilmaz, MD1*, Maro Ohanian, DO1*, Jo Ishizawa, MD, PhD4, Abhishek Maiti, MBBS5, Courtney D. DiNardo, MD, MSc6, Lucia Masarova, MD1, William G. Wierda7, Kelly S. Chien, MD8, Elias Jabbour, MD7, Danielle Hammond, MD1, Fadi G. Haddad, MD1, Koji Sasaki, MD1, Alex Bataller, MD, PhD1*, Debra Bull-Linderman, RN9*, Gautam Borthakur, MD4, Guillermo Garcia-Manero, MD1, Hagop M. Kantarjian, MD10 and Tapan M. Kadia, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
4Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX
6Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
7The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Leukemia, MD Anderson, Houston, TX
9Department of Leukemia, MD Anderson Cancer Center, Houston, TX
10University of Texas MD Anderson Cancer Center, Houston, TX

Jaime E. Connolly Rohrbach, PhD1*, Edward Waldron1*, Li Liu2*, Shawn Rivera3*, Sridevi Kayyur Subramanya3*, Violet Abraham3*, Alexander E. Perl, MD4 and Mark J. Levis5

1Daiichi Sankyo, Inc., Basking Ridge, NJ
2Daiichi Sankyo, Inc, Basking Ridge, NJ
3Navigate BioPharma Services, Inc., Carlsbad, CA
4Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
5Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD

ZePing Zhou, MD, PhD1, Yaxian Tan2*, Xingli Zhao3*, Xiaohui Suo4*, Guanchen Bai5*, Yanliang Bai, MD6*, Yunya Luo7*, Xinxiao Lu8*, Linyu Yuan8*, Congcong Zhang9*, Yinling Li10*, Sifeng Gao5*, Jilei Zhang5*, Hongling Peng, MD11*, Pengxiang Guo12*, Yingchang Mi, MD13 and Kaiqi Liu13*

1The Second Affiliated Hospital of Kunming Medical University, Kunming, Alabama, China
2Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China, Kunming, China
3Department of Hematology, Oncology Center, Tianjin People's Hospital, No. 190 jieyuan Road, Hongqiao District,, Tianjin, China
4Department of Hematology, Handan Central Hospital, Handan, Hebei, China., Handan, China
5Department of Hematology, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, Shandong, China, 271000., Taian, China
6Department of Hematology, Zhengzhou University People's Hospital and Henan Provincial People's Hospital, Zhengzhou, China
7Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, People's Republic of China., Changsha, China
8Department of Hematology, Oncology Center, Tianjin People's Hospital, No. 190 jieyuan Road, Hongqiao District, Tianjin 300121, P R China., Tianjin, China
9Department of Hematology, Handan Central Hospital, Handan, Hebei, China, 056000, Handan, China
10Department of Hematology, Handan Central Hospital, Handan, Hebei, China, 056000,, Handan, China
11Department of hematology, The second xiangya hospital of Central South University, Changsha, China
12Department of Hematology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, China, Guiyang, China
13State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China, Tianjin, China

Yafang Ma1*, Xiang Zhang2*, Jian Hou3*, Lijing Shen4*, Fei Li5, Fancong Kong6*, Ying Lu7*, Guowei Li8*, Jie Jin, M.D.9 and Wenjuan Yu10*

1The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, AL, CHN
2Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
4Department of Hematology, Renji hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
5Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
6Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
7Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China
8Department of Hematology, Huizhou Municipal Central Hospital, Huizhou, China
9Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
10Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Leora Boussi, MD1, Jan Philipp Bewersdorf, MD2, Yiwen Liu, MS3*, Rory M. Shallis, MD4, Luis E. Aguirre5*, Andrius Zucenka, MD6, Sylvain Garciaz, MD7*, Rebecca P. Bystrom, MD5, Daniel J. DeAngelo, MD, PhD8, Richard M Stone, MD9, Marlise R. Luskin, MD9, Jacqueline S. Garcia, MD9, Eric S. Winer, MD9, Evan Chen, MD10*, Martha Wadleigh, MD9, Kelly Ling, PA-C9*, Amer M. Zeidan, MBBS, MHS2, Aaron D. Goldberg1, Eytan M. Stein, MD11, Shai Shimony, MD9 and Maximilian Stahl, MD12

1Department of Medicine; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, New Haven, CT
3Data Science, Dana-Farber Cancer Institute, Boston, MA
4Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, Killingworth, CT
5Dana-Farber Cancer Institute, Boston, MA
6Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
7Institut Paoli-Calmettes, MARSEILLE, France
8Adult Leukemia Program, Dana-Farber Cancer Institute, Boston, MA
9Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
10Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
11Department of Medicine; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY
12Dana Farber Cancer Institute, Boston, MA

Michelle Hyunju Lee, MD1, Wyatt McCall, MD2*, Joanna Cwykiel, PhD3*, Chenyu Lin, MD4, Ellen Madarang, PharmD5*, Justin M. Watts, MD5, Harry P. Erba, MD, PhD4, Yasmin Abaza, MD3, Alexander E. Perl, MD6, Andrew H Matthews, MD7*, Andrew M. Brunner, MD8 and Amir T. Fathi, MD9

1Department of Medical Oncology, Massachusetts General Hospital, Boston, MA
2University of Pennsylvania, Philadelphia, PA
3Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
4Duke University Cancer Institute, Durham, NC
5Leukemia Service, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL
6Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
7Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
8Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
9Center for Leukemia, Massachusetts General Hospital Cancer Center, Boston, MA

Guopan Yu, MD, PhD1*, Zurong Yao1*, Zhao Yin1*, Yu Zhang, MD1*, Weihua Zhao, MD2*, Guangyang Weng, MD3*, Ziwen Guo4*, Zhiqiang Sun, MD, PhD5*, Pengcheng Shi1*, Xuejie Jiang, M.D.6*, Dan Xu1*, Li Xuan1* and Qifa Liu, MD1

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
3Department of Hematology, Shenzhen Second People's Hospital, Shenzhen, China
4Department of Hematology, Zhongshan City People’s Hospital, Zhongshan, China
5Department of Hematology, Shenzhen Hospital, Southern Medical University, Shenzhen, China
6Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

Xuekai Li*, Mengyun Li*, Wei Cui*, Xiaoqian Chen*, Yan Yu*, Juan Chen*, Xin Zhang*, Qingya Cui*, Depei Wu, MD, PhD and Xiaowen Tang*

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China

Manuel Jorge Fernández Villalobos1*, Javier Ortiz, MD2*, Angela Figuera Alvarez, MD, PhD3*, Carlos De Miguel, MD4*, Almudena De Laiglesia, MD5*, Virginia Pradillo Fernandez, MD6*, Marina Diaz Beya, MD7*, Jordi Esteve, MD, PhD7,8,9,10,11, Marta Polo, MD12*, Mayte Olave, MD13*, Maria del Mar Moles, MD13*, Amparo Pimentel, MD14*, Ramon Garcia-Sanz, MD, PhD15,16 and Gabriela Rodriguez Macias, MD17

1Department of Hematology, Hospital General Universitario Gregorio Marañon, Badajoz, Spain
2Department of Hematology, Hospital Universitario de La Princesa, Madrid, Spain
3Department of Hematology, Hospital Universitario de La Princesa, Madrid, Spain
4Hospital Universitario Puerta de Hierro, Madrid, Spain
5Department of Hematology, Hospital Universitario Puerta de Hierro, Madrid, Spain
6Department of Hematology., Hospital Universitario Quirónsalud, Madrid, Spain
7Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain
8Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain
9Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICHMO, Barcelona, Spain
10Universitat de Barcelona, Barcelona, Spain
11Hematology Department, Hospital Clínic Barcelona, ICAMS, Barcelona, Spain
12Department of Hematology, Hospital Universitario Clinico San Carlos, Madrid, Spain
13Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
14Department of Hematology, Hospital Universitario de Jaén, Jaén, Spain
15Health Research Institute Gregorio Marañón, Madrid, Spain
16General University Hospital Gregorio Marañón, Madrid, Spain
17Department of Hematology, Hospital Universitario Gregorio Maranon, Madrid, Spain

Uma Borate, MD1, Kaitlyn M. Dvorak-Kornaus, PhD2*, Qiuhong Zhao, MS2*, Roland B. Walter, MD, PhD, MS3, Rachel J. Cook, MD, MS4, Jennifer N. Saultz, DO5, Ronan T. Swords, MD, PhD, FRCP, FRCPath5, Nicole R. Grieselhuber, MD, PhD6, Alice Mims, MD7, Karilyn T. Larkin, MD8, Kieran D Sahasrabudhe, MD9, James S. Blachly, MD1, Gregory K Behbehani, MD, PhD8, Ann-Kathrin Eisfeld, MD1, Meixiao Long, MD, PhD8, Andrew Srisuwananukorn, MD1 and Kristin L Koenig, MD8

1The Ohio State University, Columbus, OH
2Division of Hematology, The Ohio State University, Columbus, OH
3Fred Hutchinson Cancer Center, Seattle, WA
4Oregon Health & Science University, Portland, OR
5Knight Cancer Institute, Oregon Health & Science University, Portland, OR
6Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
7The Ohio State University Comprehensive Cancer Center, Columbus, OH
8Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
9The University of Wisconsin Carbone Cancer Center, Madison, WI

Ziyu Feng, MD1*, Xiaohui Hu1*, Weiyang Li1*, Ting Xu1*, Yang Xu, MD2*, Shengli Xue2*, Huiying Qiu1*, Xiaowen Tang1*, Yue Han, MD, PhD3*, Suning Chen, MD, PhD1*, Aining Sun, MD, PhD2*, Depei Wu, MD, PhD4 and Ying Wang, MD, PhD1*

1The First Affiliated Hospital of Soochow University, Suzhou, China
2National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
3Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China
4Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China

Suravi Raychaudhuri, MD1,2, Ted Gooley, PhD2*, Allegra Rasmussen1*, Kim Quach1*, Zach Gill1*, Anna B. Halpern, MD1,2, Jacob S. Appelbaum, MD, PhD2,3, Cristina Maria Ghiuzeli, MD1,2, Paul C. Hendrie, MD, PhD1,2*, Ryan D. Cassaday, MD1,2, Roland B. Walter, MD, PhD, MS4,5, Elihu Estey, MD1,2* and Mary-Elizabeth M. Percival, MD3,6

1Fred Hutchinson Cancer Center, Seattle, WA
2University of Washington, Seattle, WA
3Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
4Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
5Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA
6Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA

Nicholas J. Short, MD1, Farhad Ravandi, MBBS2, Naval Daver, MD3, Courtney D. DiNardo, MD, MSc4, Gautam Borthakur, MD5, Tapan M. Kadia, MD1, Musa Yilmaz, MD1*, Ghayas C. Issa, MD1, Regina Abramova6*, Araceli Isabella Garza1*, Hagop M. Kantarjian, MD1 and Hussein A. Abbas, MD, PhD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
3MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
5Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
6The University of Texas MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH